ATE321534T1 - Verbesserte liposomale formulierung - Google Patents

Verbesserte liposomale formulierung

Info

Publication number
ATE321534T1
ATE321534T1 AT96918308T AT96918308T ATE321534T1 AT E321534 T1 ATE321534 T1 AT E321534T1 AT 96918308 T AT96918308 T AT 96918308T AT 96918308 T AT96918308 T AT 96918308T AT E321534 T1 ATE321534 T1 AT E321534T1
Authority
AT
Austria
Prior art keywords
liposomal formulation
improved liposomal
instability
improved
alum
Prior art date
Application number
AT96918308T
Other languages
English (en)
Inventor
Carl R Alving
Jean M Muderhwa
Original Assignee
Jenner Technologies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jenner Technologies filed Critical Jenner Technologies
Application granted granted Critical
Publication of ATE321534T1 publication Critical patent/ATE321534T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/5432—Liposomes or microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/829—Liposomes, e.g. encapsulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)
AT96918308T 1995-06-07 1996-06-06 Verbesserte liposomale formulierung ATE321534T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/480,563 US5820880A (en) 1995-06-07 1995-06-07 Liposomal formulation

Publications (1)

Publication Number Publication Date
ATE321534T1 true ATE321534T1 (de) 2006-04-15

Family

ID=23908444

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96918308T ATE321534T1 (de) 1995-06-07 1996-06-06 Verbesserte liposomale formulierung

Country Status (9)

Country Link
US (1) US5820880A (de)
EP (1) EP0831780B1 (de)
JP (1) JPH11507628A (de)
AT (1) ATE321534T1 (de)
AU (1) AU721085B2 (de)
CA (1) CA2221310A1 (de)
DE (1) DE69635987T2 (de)
ES (1) ES2262155T3 (de)
WO (1) WO1996040065A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5902604A (en) * 1995-06-06 1999-05-11 Board Of Regents, The University Of Texas System Submicron liposome suspensions obtained from preliposome lyophilizates
AU743647B2 (en) 1998-01-31 2002-01-31 Mt. Sinai School Of Medicine Of New York University Methods and reagents for decreasing allergic reactions
US7879977B2 (en) 1998-01-31 2011-02-01 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
AU5416700A (en) * 1999-05-20 2000-12-12 Fahri Saatcioglu Differentially expressed genes in prostate cancer
US7189565B2 (en) * 2001-03-23 2007-03-13 Fahri Saatcioglu Prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
AU2001249411B2 (en) * 2000-03-24 2007-02-15 Fahri Saatcioglu Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides,and diagnostic and therapeutic methods
US7611892B2 (en) * 2000-03-24 2009-11-03 President And Fellows Of Harvard College Prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
US20050063994A1 (en) * 2000-04-06 2005-03-24 Caplan Michael J. Methods and reagents for decreasing clinical reaction to allergy
US8246945B2 (en) * 2000-04-06 2012-08-21 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
CA2403292C (en) * 2000-04-06 2011-02-08 Panacea Pharmaceuticals, Llc Microbial delivery system
JP3990880B2 (ja) * 2001-07-10 2007-10-17 キヤノン株式会社 ポリヒドロキシアルカノエート被覆リポソームの製造方法
US7279163B1 (en) 2002-03-21 2007-10-09 The United States Of America, As Represented By The Secretary Of Agriculture Water-in-oil emulsion vaccines
US7914801B1 (en) 2002-03-21 2011-03-29 The United States Of America As Represented By The Secretary Of Agriculture Metabolizable oil emulsion adjuvants and vaccines for enhancing immuno-properties of antibodies and their subpopulations
EP1581187A2 (de) * 2002-12-06 2005-10-05 Board Of Regents The University Of Texas System Zusammensetzungen und verfahren bezüglich lipid-emodin-formulierungen
AU2003209580A1 (en) * 2003-02-12 2004-09-06 Institut National De La Sante Et De La Recherche Medicale (Inserm) Use of p-glycoprotein inhibitor surfactants at the surface of a colloidal carrier
CN102743382B (zh) 2005-09-19 2016-12-07 诺伊罗纳森特公司 刺激神经形成和抑制神经元变性的方法和组合物
CA2693062C (en) 2007-06-21 2016-08-09 Neuronascent, Inc. Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration using isothiazolopyrimidinones
WO2009133867A1 (ja) * 2008-05-01 2009-11-05 片山化学工業株式会社 金属コロイド含有リポソーム
US20100260830A1 (en) * 2009-04-08 2010-10-14 Brian A Salvatore Liposomal Formulations of Tocopheryl Amides
ES2968371T3 (es) 2013-10-10 2024-05-09 Eastern Virginia Medical School Derivados de 4-((2-hidroxi-3-metoxibencil)amino) bencenosulfonamida como inhibidores de la 12-lipoxigenasa
WO2023056368A1 (en) 2021-09-30 2023-04-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Cyclic peptides as non-hormonal male contraceptive agents and methods of use thereof
WO2023140901A1 (en) 2022-01-21 2023-07-27 Elanco Us Inc. Molidustat formulations and methods of use for treatment of anemia in cats

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3585967D1 (de) * 1984-03-08 1992-06-11 Phares Pharma Holland Liposombildende zusammensetzung.
US4897269A (en) * 1984-09-24 1990-01-30 Mezei Associates Limited Administration of drugs with multiphase liposomal delivery system
US5374548A (en) * 1986-05-02 1994-12-20 Genentech, Inc. Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
KR900701304A (ko) * 1988-05-05 1990-12-01 루이즈 츄이 콜린스 에이미 사람 및/또는 동물용 알레르겐 탈감작제
DE69131709T2 (de) * 1990-06-29 2000-05-25 Chiron Corp., Emeryville Liposomen enthaltende impfstoffzusammensetzungen
JPH06183953A (ja) * 1991-06-24 1994-07-05 Nippon Oil & Fats Co Ltd 混合脂質膜小胞
DK0596032T4 (da) * 1991-07-25 2004-07-26 Idec Pharma Corp Induktion af cytotoksiske T-lymfocytsvar
ZA941645B (en) * 1994-03-09 1995-01-13 South To South Co Operation In Antibodies specifically reactive against human prostate specific antigen.

Also Published As

Publication number Publication date
ES2262155T3 (es) 2006-11-16
DE69635987T2 (de) 2006-11-16
EP0831780B1 (de) 2006-03-29
EP0831780A1 (de) 1998-04-01
JPH11507628A (ja) 1999-07-06
DE69635987D1 (de) 2006-05-18
CA2221310A1 (en) 1996-12-19
WO1996040065A1 (en) 1996-12-19
AU6099796A (en) 1996-12-30
US5820880A (en) 1998-10-13
EP0831780A4 (de) 1999-05-19
AU721085B2 (en) 2000-06-22

Similar Documents

Publication Publication Date Title
ATE321534T1 (de) Verbesserte liposomale formulierung
FI953442A0 (fi) Gonadotropiinia sisältäviä pakastekuivattuja pallosia
ATE198143T1 (de) Zahnpasten
DK0758248T3 (da) Formuleringer til faktor IX
BG104247A (en) Resorcinol derivatives
IT1275955B1 (it) Formulazioni farmaceutiche in forma di gel tissotropico
DK0825847T3 (da) Tandrensningspræparater
BR9910960A (pt) Composição de higiene pessoal
DE68920336D1 (de) Parfüm enthaltendes Reinigungsmittel.
TR200001012T2 (tr) Yeni ariloksi-alkil-dialkilaminler.
TR28023A (tr) Yüzeyaktif iyon cifti floresanli beyazlatici terkipleri.
TR199800415T1 (en) Farmas�tik form�lasyon.
MX9804588A (es) Uso de composiciones que comprenden blanqueador de halogeno para suavidad mejorada a la piel.
HUP0001970A2 (hu) Gombaellenes szert és foszfolipidet tartalmazó készítmények
ITBO970640A0 (it) Apparecchio per l'elettroemanazione di principi attivi.
IT1243193B (it) Composizioni farmaceutiche orali a base di melatonina
IT1250672B (it) Formulazioni orali di ubidecarenone in soluzione acquosa
ATE120718T1 (de) Herstellung von peroxidzusammensetzungen.
ATE110261T1 (de) Feste orale applikationsformen, die als wirkstoff ifosfamid enthalten.
DE69431662D1 (de) Stabilisierte tablettenformulierung
HUP9903832A2 (hu) Fehérítő prekurzor készítmény
ES2090170T3 (es) Agente de recubrimiento espermicida.
ITTO910815A0 (it) Preparazione enzimatica solida esente da tensioattivi,contenente pro teasi come enzima attivo
NO20021429L (no) 1,4-dioksacykloalkan-2-oner og 1,4-dioksacykloalken-2-oner
DE69614552D1 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties